Skip to main content

Table 2 Surgical remission rates of patients with acromegaly

From: Prolonged preoperative treatment of acromegaly with Somatostatin analogs may improve surgical outcome in patients with invasive pituitary macroadenoma (Knosp grades 1–3): a retrospective cohort study conducted at a single center

  

Preoperative medical therapy

Primary surgery

P

Remission rate for GH

Total (%)

46/81 (56.8)

143/277 (51.6)

0.41

Microadenoma (%)

10/10 (100)

18/29 (62.1)

0.037

Macroadenoma (%)

36/71 (50.7)

125/248 (50.4)

0.96

Remission rate for IGF-1

Total (%)

32/79 (40.5)

83/255 (32.6)

0.19

Microadenoma (%)

6/10 (60)

10/28 (35.7)

0.267

Macroadenoma (%)

26/69 (37.7)

73/227 (32.2)

0.39